The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases

Kamila Wójcik-Cichy; Ewa Koślińska-Berkan; Anna Piekarska

doi:10.5114/ceh.2018.73155

eISSN: 2449-8238
ISSN: 2392-1099

Clinical and Experimental Hepatology

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2018
vol. 4

Send email

Copy url:

abstract:

Review paper

The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases

Kamila Wójcik-Cichy

,

Ewa Koślińska-Berkan

,

Anna Piekarska

Clin Exp HEPATOL 2018; 4, 1: 1-6

DOI: https://doi.org/10.5114/ceh.2018.73155

Online publish date: 2018/01/20

View full text Get citation

PlumX metrics:

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in developed countries and is associated with obesity, dyslipidaemia, diabetes, and metabolic syndrome. Atherosclerosis and cardiovascular diseases are also highly prevalent in this group of patients, due to the presence of shared risk factors. The incidences of coronary artery calcification, hypertension, aortic valve sclerosis, diastolic dysfunction, atherosclerotic plaques, and increased carotid intima-media thickness were more common in patients with NAFLD than in those without. The present paper reviews the medical literature concerning the association between NAFLD and cardiovascular events.

keywords:

The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases

Kamila Wójcik-Cichy , Ewa Koślińska-Berkan , Anna Piekarska

non-alcoholic fatty liver disease, ischaemic heart disease, atherosclerosis

Kamila Wójcik-Cichy

,

Ewa Koślińska-Berkan

,

Anna Piekarska